Cargando…

Identification of an immune gene signature for predicting the prognosis of patients with uterine corpus endometrial carcinoma

BACKGROUND: Uterine corpus endometrial carcinoma (UCEC) is a frequent gynecological malignancy with a poor prognosis particularly at an advanced stage. Herein, this study aims to construct prognostic markers of UCEC based on immune-related genes to predict the prognosis of UCEC. METHODS: We analyzed...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhou, Cankun, Li, Chaomei, Yan, Fangli, Zheng, Yuhua
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Primary Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7650210/ https://www.ncbi.nlm.nih.gov/pubmed/33292199 http://dx.doi.org/10.1186/s12935-020-01560-w

Ejemplares similares

Identification of immune-related gene signature for predicting prognosis in uterine corpus endometrial carcinoma
por: Song, Siyuan, et al.
Publicado: (2023)

Identification of methylation-driven genes prognosis signature and immune microenvironment in uterus corpus endometrial cancer
por: Liu, JinHui, et al.
Publicado: (2021)

Identification of pyroptosis-related signature for cervical cancer predicting prognosis
por: Zhou, Cankun, et al.
Publicado: (2021)

Tumor mutation burden in connection with immune-related survival in uterine corpus endometrial carcinoma
por: Zhao, Ling, et al.
Publicado: (2021)

Identification and validation of oxeiptosis-associated lncRNAs and prognosis-related signature genes to predict the immune status in uterine corpus endometrial carcinoma
por: Niu, Linjun, et al.
Publicado: (2023)

Inflammation-Related LncRNAs Signature for Prognosis and Immune Response Evaluation in Uterine Corpus Endometrial Carcinoma
por: Gu, Hongmei, et al.
Publicado: (2022)

Endoplasmic reticulum stress related IncRNA signature predicts the prognosis and immune response evaluation of uterine corpus endometrial carcinoma
por: Chen, Jun, et al.
Publicado: (2023)

The IFN-γ-related long non-coding RNA signature predicts prognosis and indicates immune microenvironment infiltration in uterine corpus endometrial carcinoma
por: Gu, Chunyan, et al.
Publicado: (2022)

Identification of novel key genes associated with uterine corpus endometrial carcinoma progression and prognosis
por: Li, Haixia, et al.
Publicado: (2023)

Comprehensive Analysis of a Novel Lipid Metabolism-Related Gene Signature for Predicting the Prognosis and Immune Landscape in Uterine Corpus Endometrial Carcinoma
por: Tan, Xiaofang, et al.
Publicado: (2022)

Elevated Expression of Gamma-Glutamyl Hydrolase Is Associated With Poor Prognosis and Altered Immune Signature in Uterine Corpus Endometrial Carcinoma
por: Yu, Cong, et al.
Publicado: (2022)

Comprehensive Analysis of Prognosis and Immune Landscapes Based on Lipid-Metabolism- and Ferroptosis-Associated Signature in Uterine Corpus Endometrial Carcinoma
por: Yang, Pusheng, et al.
Publicado: (2023)

CXCL9 correlates with antitumor immunity and is predictive of a favorable prognosis in uterine corpus endometrial carcinoma
por: Xue, Shen, et al.
Publicado: (2023)

Comprehensive Analysis of the Expression and Prognosis for MCM4 in Uterine Corpus Endometrial Carcinoma
por: Pei, Li-Peng, et al.
Publicado: (2022)

Development of an Oxidative Phosphorylation-Related and Immune Microenvironment Prognostic Signature in Uterine Corpus Endometrial Carcinoma
por: Liu, Jinhui, et al.
Publicado: (2021)

BTG1 inhibits malignancy as a novel prognosis signature in endometrial carcinoma
por: Li, Yibing, et al.
Publicado: (2020)

Identification of the Prognostic Signature Associated With Tumor Immune Microenvironment of Uterine Corpus Endometrial Carcinoma Based on Ferroptosis-Related Genes
por: Liu, Jinhui, et al.
Publicado: (2021)

Identification and Validation of Cuproptosis-Related Prognostic Signature and Associated Regulatory Axis in Uterine Corpus Endometrial Carcinoma
por: Chen, Yun
Publicado: (2022)

Establishment of a novel cell cycle-related prognostic signature predicting prognosis in patients with endometrial cancer
por: Liu, Jinhui, et al.
Publicado: (2020)

Identification of an integrated kinase-related prognostic gene signature associated with tumor immune microenvironment in human uterine corpus endometrial carcinoma
por: Wei, Sitian, et al.
Publicado: (2022)

RNF183 Is a Prognostic Biomarker and Correlates With Tumor Purity, Immune Infiltrates in Uterine Corpus Endometrial Carcinoma
por: Geng, Rong, et al.
Publicado: (2020)

Identification of novel cell glycolysis related gene signature predicting survival in patients with endometrial cancer
por: Wang, Zi-Hao, et al.
Publicado: (2019)

Immune-related gene signature for predicting the prognosis of head and neck squamous cell carcinoma
por: She, Yangyang, et al.
Publicado: (2020)

Immune signature-based hepatocellular carcinoma subtypes may provide novel insights into therapy and prognosis predictions
por: Zheng, Qiuxian, et al.
Publicado: (2021)

N1-Methyladenosine-Related lncRNAs Are Potential Biomarkers for Predicting Prognosis and Immune Response in Uterine Corpus Endometrial Carcinoma
por: Liu, Jinhui, et al.
Publicado: (2022)

ZBTB7A, a potential biomarker for prognosis and immune infiltrates, inhibits progression of endometrial cancer based on bioinformatics analysis and experiments
por: Geng, Rong, et al.
Publicado: (2020)

Relationship between Prognosis, Immune Infiltration Level, and Differential Expression of PARVG Gene in Uterine Corpus Endometrial Carcinoma
por: Wang, Fei, et al.
Publicado: (2022)

Identification and validation a costimulatory molecule gene signature to predict the prognosis and immunotherapy response for hepatocellular carcinoma
por: Hu, Yinan, et al.
Publicado: (2022)

A novel tumor doubling time-related immune gene signature for prognosis prediction in hepatocellular carcinoma
por: Zhang, Genhao, et al.
Publicado: (2021)

Identification of m7G Methylation-Related miRNA Signature Associated with Survival and Immune Microenvironment Regulation in Uterine Corpus Endometrial Carcinoma
por: Chen, Rujun, et al.
Publicado: (2022)

Identification of a 6-gene signature predicting prognosis for colorectal cancer
por: Zuo, Shuguang, et al.
Publicado: (2019)

Exploring Prognosis-Associated Biomarkers of Estrogen-Independent Uterine Corpus Endometrial Carcinoma by Bioinformatics Analysis
por: Ye, Youchun, et al.
Publicado: (2021)

FAT2 mutation is associated with better prognosis and responsiveness to immunotherapy in uterine corpus endometrial carcinoma
por: Wang, Zhe, et al.
Publicado: (2022)

Development and validation of a novel DNA damage repair-related long non-coding RNA signature in predicting prognosis, immunity, and drug sensitivity in uterine corpus endometrial carcinoma
por: Wang, Tao, et al.
Publicado: (2023)

Retracted: Relationship between Prognosis, Immune Infiltration Level, and Differential Expression of PARVG Gene in Uterine Corpus Endometrial Carcinoma
por: Imaging, Contrast Media & Molecular
Publicado: (2023)

A Risk Signature with Nine Stemness Index-Associated Genes for Predicting Survival of Patients with Uterine Corpus Endometrial Carcinoma
por: Xu, Haoya, et al.
Publicado: (2021)

Construction of a ferroptosis-related five-lncRNA signature for predicting prognosis and immune response in thyroid carcinoma
por: Qin, Yuan, et al.
Publicado: (2022)

Prognostic significance of mutant-allele tumor heterogeneity in uterine corpus endometrial carcinoma
por: Hou, Yufang, et al.
Publicado: (2020)

Metabolism-associated molecular classification of uterine corpus endometrial carcinoma
por: Zhao, Munan, et al.
Publicado: (2023)

A robust twelve-gene signature for prognosis prediction of hepatocellular carcinoma
por: Ouyang, Guoqing, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_j1548ro94tcm35k51ei9d7482u